All (n=120)

25 (OH) Vitamin D Levels

p-value

Patient characteristics

 

<20

20-30

>30

Age (median)

120 (46.1)

44.1

48.9

47.6

0.13

Sex, n (% exposed)

 

 

 

 

0.47

Male

85 (70.8)

43 (50.6)

25 (29.4)

17 (20.0)

 

Female

35 (29.2)

22 (62.9)

7 (20.0)

6 (17.1)

 

Race, n(% exposed)

 

 

 

 

<0.001

White

30 (25.0)

8 (26.7)

10 (33.3)

12 (40.0)

 

Black

81 (67.5)

54 (66.7)

19 (23.4)

8 (9.9)

 

Hispanic

7 (5.8)

3 (42.8)

2 (28.6)

2 (28.6)

 

Asian

2 (1.7)

0 (0)

1 (50.0)

1 (50.0)

 

CD4 count, n(% exposed)

 

 

 

 

0.39

≤ 350 cells/mm3

36 (30.0)

23 (63.9)

7 (19.4)

6 (16.6)

 

> 350 cells/mm3

84 (70.0)

42 (50.0)

25 (29.8)

17 (20.2)

 

Viral load, n(% exposed)

 

 

 

 

0.01

< 400 copies/ml

110 (91.6)

55 (50.0)

32 (29.1)

23 (20.9)

 

≥ 400 copies/ml

10 (8.4)

10 (100)

0 (0)

0 (0)

 

Table 1: Demographic and clinical characteristics of 120 patients with HIV infection, by vitamin D level.